![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Taizhou City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Gliclazide, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2003-138 - Rev 01
This Chemical Type CEP, issued on December 09, 2014, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1524 associated with this CEP further emphasizes